Replies to post #798496 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Yes, an ASM was due this year but that has nothing to do with needing to raise the authorized shares by nearly a billion. You don’t increase A/S by 900M shares “just in case” or “to avoid a mess.” Companies only do that when they expect continued dilution before a major catalyst, not after it.

And the idea that NWBO “must” raise A/S because they “don’t know what MHRA is waiting for” is backwards. If they were anywhere near approval, they would not pre-emptively increase the authorization. They would wait, because approval itself changes their entire financing landscape. The fact that they are raising A/S before MHRA clarity tells you exactly what the company knows internally: the timeline is not close, and they need runway for whatever CMC work remains.

Also, if a third-party agreement depends on approval, you don’t need more authorized shares now because such a deal only triggers after approval, when the stock is much higher and dilution is far less of an issue. So no this isn’t administrative housekeeping. It’s a signal that financing will be required while the MHRA timeline remains uncertain, which is only the case if CMC expansion (likely Flaskworks/Eden) is still in review.

[KRISGO]

Honestly, I’d vote Yes if they would just explain the reason for the delay and why the MAA approval is stuck. I don’t really care whether they have a buyout lined up or not—what shareholders need before voting “Yes” is simply the truth. Even though I hold over a million shares, my individual “Yes” or “No” vote may not matter much, but I still want transparency.
Here’s my assumption: I think management already knew there would be a long delay, even before the Advent merger, and that this was one of the reasons they moved forward with it. By showing the merger as progress, they could justify requesting dilution at the ASM while waiting for approval.
As someone mentioned, if Merck is supposedly building major facilities for Northwest, why can’t they lend us $25 million if they truly believe in eventually acquiring Northwest Bio outright? If my guess is correct, the partner they have in mind may not even be a large company—maybe something more comparable to our size. But honestly, I don’t care whether the partner is big or small, because once approval comes through, everything changes anyway.

[Investor082]

LOL, flipper doing his thing! ;) It seems your contract has been renewed since the last couple of days. Thats how you plan to make money. I misunderstood when in one of your last messages you said you still plan to make money off this investment when you left this board for a bit after you lost the challenge. Perhaps the contract was paused at that time due to funding crunch? LOL! ;)

[learningcurve2020]

Oh come on! Of course they did, assuming L and Advent were legitimate money makers.

>>They simply didn’t have a choice